DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» XPO1
XPO1
XPO1E571K Mutation Modifies Exportin 1 Localisation And
1325.Full-Text.Pdf
Inhibition of the Nuclear Export Receptor XPO1 As a Therapeutic Target for Platinum-Resistant Ovarian Cancer Ying Chen1, Sandra Catalina Camacho1, Thomas R
KPT-350 (And Other XPO1 Inhibitors)
Renal Medullary Carcinomas Depend Upon SMARCB1 Loss And
Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling Fabio Conforti1, Yisong Wang1,2, Jose A
A Member of the Ran-Binding Protein Family, Yrb2p, Is Involved in Nuclear Protein Export
Frequent Somatic Mutations in Components of the RNA Processing Machinery in Chronic Lymphocytic Leukemia
Microduplication in the 2P16.1P15 Chromosomal Region Linked To
Inhibition of the Nuclear Export Receptor XPO1 As a Therapeutic Target for Platinum-Resistant Ovarian Cancer Ying Chen1, Sandra Catalina Camacho1, Thomas R
XPO1 Inhibitor KPT-330 Synergizes with Bcl-Xl Inhibitor to Induce
Renal Medullary Carcinomas Depend Upon SMARCB1 Loss and Are Sensitive to 2 Proteasome Inhibition 3 4 5 Andrew L
Genitourinary Defects Associated with Genomic Deletions in 2P15 Encompassing OTX1
XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
Oncomine Comprehensive Assay V3 Empower Your Oncology Research with Proven Ion Torrent Technology
Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors
Promising Sines for Embargoing Nuclear–Cytoplasmic Export As an Anticancer Strategy
Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling Fabio Conforti1, Yisong Wang1,2, Jose A
Top View
Biology and Treatment of Renal Tumours in Childhood
A Comparative Genomic Approach for Identifying Synthetic Lethal Interactions in Human Cancer
Clinical Implications of Targeting XPO1-Mediated Nuclear Export in Multiple Myeloma
JAX SOMASEQ TM Technical Specifications
Snapshot: Nuclear Transport Elizabeth J
Characterization of SARS-Cov-2 Proteins Reveals Orf6 Pathogenicity
Erα-XPO1 Crosstalk Controls Tamoxifen Sensitivity in Tumors By
Targeted CRM1-Inhibition Perturbs Leukemogenic NUP214 Fusion Proteins and Exerts Anti
XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL
Glans Metastatic Extra-Nodal Natural Killer/T-Cell Lymphoma, Nasal-Type with HDAC Inhibitor As Maintenance Therapy: a Rare Case Report with Literature Review
Next-Generation XPO1 Inhibitor Shows Improved Efficacy and in Vivo
Identification of Small Molecule Inhibitors Targeting Truncated
Cytoplasmic Location of NR4A1 in Aggressive Lymphomas Is
A Nuclear Export Sequence Promotes CRM1-Dependent Targeting of the Nucleoporin Nup214 to the Nuclear Pore Complex Mohamed Hamed, Birgit Caspar, Sarah A
Biochemical Characterization of the Nup62·58·54 Nucleoporin Complex and Mutational Analysis of the Exportin CRM1
Mutational Signatures in Cytogenetic Risk Groups of De Novo AML and MDS
Aim: to Examine the Safety and Tolerability of Selinexor When Given in Combination with Standard Chemotherapy and Immunotherapy Regimens
2P15p16.1 Microdeletion Syndrome